Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma

Human Pathology

Volumn 46, Issue 3, 2015, Pages 454-460

  Park, Jeong Hwan ^a   Lee, Cheol ^a   Suh, Ja Hee ^a   Chae, Ji Yoen ^a   Kim, Hwal Woong ^b   Moon, Kyung Chul ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Good Moonhwa Hospital   (South Korea)

Author keywords

ARID1A; Clear cell renal cell carcinoma; Immunohistochemistry; Prognosis; Progression

Indexed keywords

RETINOBLASTOMA BINDING PROTEIN 2; ARID1A PROTEIN, HUMAN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; CELL NUCLEUS; CHEMISTRY; DISEASE COURSE; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CELL NUCLEUS; CHILD; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; SURVIVAL; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84924358230     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.12.002     Document Type: Article

References (30)

1. W.H. Chow, L.M. Dong, and S.S. Devesa Epidemiology and risk factors for kidney cancer Nat Rev Urol 7 2010 245 257
2. B.I. Rini, W.K. Rathmell, and P. Godley Renal cell carcinoma Curr Opin Oncol 20 2008 300 306
3. W.M. Linehan, R. Srinivasan, and L.S. Schmidt The genetic basis of kidney cancer: a metabolic disease Nat Rev Urol 7 2010 277 285
4. I. Varela, P. Tarpey, and K. Raine Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma Nature 469 2011 539 542
5. Cancer Genome Atlas Research Network Comprehensive molecular characterization of clear cell renal cell carcinoma Nature 499 2013 43 49
6. Z. Lichner, A. Scorilas, and N.M. White The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma Am J Pathol 182 2013 1163 1170
7. B.G. Wilson, and C.W. Roberts SWI/SNF nucleosome remodellers and cancer Nat Rev Cancer 11 2011 481 492
8. K.C. Wiegand, S.P. Shah, and O.M. Al-Agha ARID1A mutations in endometriosis-associated ovarian carcinomas N Engl J Med 363 2010 1532 1543
9. G. Allo, M.Q. Bernardini, and R.C. Wu ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas Mod Pathol 27 2014 255 261
10. D.D. Wang, Y.B. Chen, and K. Pan Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer PLoS One 7 2012 e40364
11. C. Balbas-Martinez, M. Rodriguez-Pinilla, and A. Casanova ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors PLoS One 8 2013 e62483
12. J. Zhao, C. Liu, and Z. Zhao ARID1A: a potential prognostic factor for breast cancer Tumour Biol 35 2014 4813 4819
13. S.A. Fuhrman, L.C. Lasky, and C. Limas Prognostic significance of morphologic parameters in renal cell carcinoma Am J Surg Pathol 6 1982 655 663
14. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti AJCC Cancer Staging Manual 7th ed. 2009 Springer New York 479 489
15. X. Wang, N.G. Nagl Jr., S. Flowers, D. Zweitzig, P.B. Dallas, and E. Moran Expression of p270 (ARID1A), a component of human SWI/SNF complexes, in human tumors Int J Cancer 112 2004 636
16. S. Yamamoto, H. Tsuda, M. Takano, S. Tamai, and O. Matsubara Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations Mod Pathol 25 2012 615 624
17. B. Guan, T.L. Wang, and IeM Shih ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers Cancer Res 71 2011 6718 6727
18. J.H. Park, C. Lee, J.H. Suh, J.Y. Chae, and K.C. Moon Nuclear expression of Smad proteins and its prognostic significance in clear cell renal cell carcinoma Hum Pathol 44 2013 2047 2054
19. N.G. Nagl Jr., A. Patsialou, D.S. Haines, P.B. Dallas, G.R. Beck Jr., and E. Moran The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest Cancer Res 65 2005 9236 9244
20. N.G. Nagl Jr., D.R. Zweitzig, B. Thimmapaya, G.R. Beck Jr., and E. Moran The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest Cancer Res 66 2006 1289 1293
21. P.M. Gilbert, J.K. Mouw, and M.A. Unger HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype J Clin Invest 120 2010 1535 1550
22. C. Van Rechem, G. Boulay, and D. Leprince HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A Biochem Biophys Res Commun 385 2009 586 590
23. H. Shigetomi, A. Oonogi, and T. Tsunemi The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary (Review) Oncol Lett 2 2011 591 597
24. D. Reisman, S. Glaros, and E.A. Thompson The SWI/SNF complex and cancer Oncogene 28 2009 1653 1668
25. Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
26. A.H. Girgis, V.V. Iakovlev, and B. Beheshti Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma Cancer Res 72 2012 5273 5284
27. H. Zhang, Y. Zhai, and Z. Hu Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers Nat Genet 42 2010 755 758
28. J.C. Shultz, R.W. Goehe, and C.S. Murudkar SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells Mol Cancer Res 9 2011 889 900
29. N. Lin, C. Di, and K. Bortoff Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma Mol Cancer Res 10 2012 208 217
30. G.L. Dalgliesh, K. Furge, and C. Greenman Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes Nature 463 2010 360 363